Antisense glutaminase inhibition modifies the O-GlcNAc pattern and flux through the hexosamine pathway in breast cancer cells

Journal of Cellular Biochemistry

Volumn 103, Issue 3, 2008, Pages 800-811

  Donadio, Ana C ^a   Lobo, Carolina ^b   Tosina, Marta ^b   De La Rosa, Vanessa ^b   Martín Rufián, Mercedes ^b   Campos Sandoval, José A ^b   Matés, José M ^b   Márquez, Javier ^b   Alonso, Francisco J ^b   Segura, Juan A ^b  

^a UNIVERSIDAD NACIONAL DE CÓRDOBA   (Argentina)

^b UNIVERSITY OF MÁLAGA   (Spain)

Author keywords

Antisense mRNA; Glutaminase; O GlcNAc transferase (OGT); O glycosylation; Sp1

Indexed keywords

CHAPERONIN; GLUTAMINASE; GLUTAMINE FRUCTOSE 6 PHOSPHATE AMINOTRANSFERASE; HEXOSAMINE; MESSENGER RNA; TRANSCRIPTION FACTOR SP1;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEOMICS;

ANIMALS; BREAST NEOPLASMS; GENE EXPRESSION; GLUTAMINASE; GLUTAMINE; HEXOSAMINES; HUMANS; MICE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOMICS; RNA INTERFERENCE; SP1 TRANSCRIPTION FACTOR; TUMOR CELLS, CULTURED; URIDINE DIPHOSPHATE N-ACETYLGLUCOSAMINE;

EID: 39049119494     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21449     Document Type: Article

References (44)

1. Aledo JC. 2004. Glutamine breakdown in rapidly dividing cells: Waste or investment? Bioessays 26:778-785.
2. Aledo JC, Gómez-Fabre PM, Olalla L, Márquez J. 2000. Identification of two human glutaminase loci and tissue-specific expression of the two related genes. Mamm Genome 11:1107-1110.
3. Brasse-Lagnel C, Fairand A, Lavoinne A, Husson A. 2003. Glutamine stimulates argininosuccinate synthetase gene expression through cytosolic O-glycosylation of Sp1 in Caco-2 cells. J Biol Chem 278:52504-52510.
4. Broschat KO, Gorka C, Page JD, Martin-Berger CL, Davies MS, Huang Hc HC, Gulve EA, Salsgiver WJ, Kasten TP. 2002. Kinetic characterization of human glutamine-fructose-6-phosphate amidotransferase I: Potent feedback inhibition by glucosamine 6-phosphate. J Biol Chem 277:14764-14770.
5. Chang Q, Su K, Baker JR, Yang X, Paterson AJ, Kudlow JE. 2000. Phosphorylation of human glutamine:fructose-6-phosphate amidotransferase by cAMP-dependent protein kinase at serine 205 blocks the enzyme activity. J Biol Chem 275:21981-21987.
6. Curthoys NP, Watford M. 1995. Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15:133-159.
7. Daniels MC, Ciaraldi TP, Nikoulina S, Henry RR, McClain DA. 1996. Glutamine:fructose-6-phosphate amidotransferase activity in cultured human skeletal muscle cells: Relationship to glucose disposal rate in control and non-insulin-dependent diabetes mellitus subjects and regulation by glucose and insulin. J Clin Invest 97:1235-1241.
8. Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, et al. 1994. The Ewing family of tumors-a subgroup of small-round-cell tumors defined by specific chimeric transcripts. N Engl J Med 331:294-299.
9. Elgadi KM, Meguid RA, Qian M, Souba WW, Abcouwer SF. 1999. Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics 1:51-62.
10. Frydman J. 2001. Folding of newly translated proteins in vivo: The role of molecular chaperones. Annu Rev Biochem 70:603-647.
11. Gómez-Fabre PM, Aledo JC, Castillo-Olivares A, Alonso FJ, Núñez de Castro I, Campos JA, Márquez J. 2000. Molecular cloning, sequencing and expression studies of the human breast cancer cell glutaminase. Biochem J 345:365-375.
12. Heini HG, Gebhardt R, Brecht A, Mecke D. 1987. Purification and characterization of rat liver glutaminase. Eur J Biochem 162:541-546.
13. Holt GD, Hart GW. 1986. The subcellular distribution of terminal N-acetylglucosamine moieties. Localization of a novel protein-saccharide linkage, O-linked GlcNAc. J Biol Chem 261:8049-8057.
14. Jackson SP, Tjian R. 1988. O-glycosylation of eukaryotic transcription factors: Implications for mechanisms of transcriptional regulation. Cell 55:125-133.
15. Ko YG, Kim EY, Kim T, Park H, Park HS, Choi EJ, Kim S. 2001. Glutamine-dependent antiapoptotic interaction of human glutaminyl-tRNA synthetase with apoptosis signal-regulating kinase 1. J Biol Chem 276:6030-6036.
16. Konrad RJ, Mikolaenko I, Tolar JF, Liu K, Kudlow JE. 2001. The potential mechanism of the diabetogenic action of streptozotocin: Inhibition of pancreatic beta-cell O-GlcNAc-selective N-acetyl-beta-D-glucosaminidase. Biochem J 356:31-41.
17. Kouzmenko AP, Takeyama K, Ito S, Furutani T, Sawatsubashi S, Maki A, Suzuki E, Kawasaki Y, Akiyama T, Tabata T, Kato S. 2004. Wnt/beta-catenin and estrogen signaling converge in vivo. J Biol Chem 279:40255-40258.
18. Lobo C, Ruía-Bellido MA, Aledo JC, Márquez J, Núñez de Castro I, Alonso FJ. 2000. Inhibition of glutaminase expression by antisense mRNA decreases growth and tumorigenicity of tumor cells. Biochem J 348:257-261.
19. Lora J, Alonso FJ, Segura JA, Lobo C, Márquez J, Matés JM. 2004. Antisense glutaminase inhibition decreases glutathione antioxidant capacity and increases apoptosis in Ehrlich ascitic tumour cells. Eur J Biochem 271:4298-4306.
20. Márquez J, Núñez de Castro I. 1991. Mouse liver free amino acids during the development of Ehrlich ascites tumour. Cancer Lett 58:221-224.
21. Márquez J, de la Oliva AR, Matés JM, Segura JA, Alonso FJ. 2006. Glutaminase: A multifaceted protein not only involved in generating glutamate. Neurochem Int 48:465-471.
22. Matés JM, Segura JA, Alonso FJ, Márquez J. 2006. Pathways from glutamine to apoptosis. Front Biosci 11:3164-3180.
23. McLaughlin F, Ludbrook VJ, Cox J, von Carlowitz I, Brown S, Randi AM. 2001. Combined genomic and antisense analysis reveals that the transcription factor Erg is implicated in endothelial cell differentiation. Blood 98:3332-3339.
24. Medina MA, Sánchez Jiménez F, Márquez J, Rodríguez Quesada A, Nuñez de Castro I. 1992. Relevance of glutamine metabolism to tumor cell growth. Mol Cell Biochem 113:1-15.
25. Morin PJ. 1999. Beta-catenin signaling and cancer. Bioessays 21:1021-1030.
26. Murakami K, Mavrothalassitis G, Bhat NK, Fisher RJ, Papas TS. 1993. Human ERG-2 protein is a phosphorylated DNA-binding protein-a distinct member of the ets family. Oncogene 8:1559-1566.
27. Nakajo T, Yamatsuji T, Ban H, Shigemitsu K, Haisa M, Motoki T, Noma K, Nobuhisa T, Matsuoka J, Gunduz M, Yonezawa K, Tanaka N, Naomoto Y. 2005. Glutamine is a key regulator for amino acid-controlled cell growth through the mTOR signaling pathway in rat intestinal epithelial cells. Biochem Biophys Res Commun 326:174-180.
28. Olalla L, Gutiérrez A, Campos JA, Khan ZU, Alonso FJ, Segura JA, Márquez J, Aledo JC. 2002. Nuclear localization of L-type glutaminase in mammalian brain. J Biol Chem 277:38939-38944.
29. Pérez-Gómez C, Campos-Sandoval JA, Alonso FJ, Segura JA, Manzanares E, Ruíz-Sánchez P, González ME, Márquez J, Matés JM. 2005. Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem J 386:535-542.
30. Rhoads JM, Argenzio RA, Chen W, Rippe RA, Westwick JK, Cox AD, Berschneider HM, Brenner DA. 1997. L-glutamine stimulates intestinal cell proliferation and activates mitogen-activated protein kinases. Am J Physiol 272:G943-953.
31. Sayeski PP, Kudlow JE. 1996. Glucose metabolism to glucosamine is necessary for glucose stimulation of transforming growth factor-alpha gene transcription. J Biol Chem 271:15237-15243.
32. Segura JA, Ruíz-Bellido MA, Arenas M, Lobo C, Márquez J, Alonso FJ. 2001. Ehrlich ascites tumor cells expressing anti-sense glutaminase mRNA lose their capacity to evade the mouse immune system. Int J Cancer 91:379-384.
33. Segura JA, Donadio AC, Lobo C, Mates JM, Márquez J, Alonso FJ. 2005. Inhibition of glutaminase expression increases SpI phosphorylation and Sp1/Sp3 transcriptional activity in Ehrlich tumor cells. Cancer Lett 218:91-98.
34. Slawson C, Housley MP, Hart GW. 2006. O-GlcNAc cycling: How a single sugar post-translational modification is changing the way we think about signaling networks. J Cell Biochem 97:71-83.
35. Smith EM, Watford M. 1990. Molecular cloning of a cDNA for rat hepatic glutaminase. Sequence similarity to kidney-type glutaminase. J Biol Chem 265:10631-10636.
36. Souba WW. 1993. Glutamine and cancer. Ann Surg 218:715-728.
37. Tapiero H, Mathe G, Couvreur P, Tew KD. 2002. II. Glutamine and glutamate. Biomed Pharmacother 56:446-457.
38. Torres CR, Hart GW. 1984. Topography and polypeptide distribution of terminal N-acetyLglucosamine residues on the surfaces of intact lymphocytes. Evidence for O-linked GlcNAc. J Biol Chem 259:3308-3317.
39. Turner A, McGivan JD. 2003. Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem J 370:403-408.
40. Tzagarakis-Foster C, Geleziunas R, Lomri A, An J, Leitman DC. 2002. Estradiol represses human T-cell leukemia virus type 1 Tax activation of tumor necrosis factor-alpha gene transcription. J Biol Chem 277:44772-44777.
41. Wells L, Vosseller K, Hart GW. 2001. Glycosylation of nucleocytoplasmic proteins: Signal transduction and O-GlcNAc. Science 291:2376-2378.
42. Yang X, Su K, Roos MD, Chang Q, Paterson AJ, Kudlow JE. 2001. O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability. Proc Natl Acad Sci U S A 98:6611-6616.
43. Zachara NE, Hart GW. 2004. O-GlcNAc a sensor of cellular state: The role of nucleocytoplasmic glycosylation in modulating cellular function in response to nutrition and stress. Biochim Biophys Acta 1673:13-28.
44. Zhang F, Su K, Yang X, Bowe DB, Paterson AJ, Kudlow JE. 2003. O-GlcNAc modification is an endogenous inhibitor of the proteasome. Cell 115:715-725.